http://www.igenericdrugs.com Review Rating: 100 out of 100 based on 561 reviews. 561 stars
Generic drugs
List of interchangeable brand and generic drugs
compare generic drug prices
 

LYCOR CREAM

Search a suitable generic or branded drugs, if you could not find the prescribed medicine. This site does not supply any medicines. It contains prices for information purposes only.
You should consult a doctor about the dosage before using this medicine!

DRUG NAME:     

 

LYCOR CREAM uses and description

Sort by popularity
LYCOR CREAM - LYCOR CREAM is in a class of drugs called steroids. LYCOR CREAM prevents the release of substances in the body that cause inflammation.

LYCOR CREAM is used to treat many different conditions such as allergic disorders, skin conditions, ulcerative colitis, arthritis, lupus, psoriasis, or breathing disorders.

LYCOR CREAM may also be used for other purposes not listed in this medication guide.

Pharmacology: Short-acting glucocorticoid that depresses formation, release, and activity of endogenous mediators of inflammation including prostaglandins, kinins, histamine, liposomal enzymes, and complement system. Also modifies body\'s immune response.

Indication: Treatment of primary or secondary adrenal cortex insufficiency, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, allergic and inflammatory ophthalmic processes, respiratory diseases, hematologic disorders (idiopathic thrombocytopenic purpura), neoplastic diseases, edematous states (resulting from nephrotic syndrome), GI diseases (ulcerative colitis and sprue), multiple sclerosis, tuberculous meningitis, trichinosis with neurologic or myocardial involvement.

Intra-articular or soft tissue administration

Treatment of synovitis of osteoarthritis and symptoms of rheumatoid arthritis, bursitis, acute gouty arthritis, epicondylitis, acute nonspecific tenosynovitis, and post-traumatic osteoarthritis.

Intralesional administration

Treatment of keloids, lesions of lichen planus, psoriatic plaques, granuloma annulare, lichen simplex chronicus, discoid lupus erythematosus, necrobiosis lipoidica diabeticorum, alopecia areata, and cystic tumors of aponeurosis or tendon.

Topical administration

Treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, management of refractory lesions of psoriasis, and other deep-seated dermatoses; hygienic cleansing of irritated perianal and external vaginal areas.

Rectal administration

Relief of discomfort associated with hemorrhoids, perianal itching, or irritation.

Glucocorticosteroid. Inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

Inhibits the activity of phospholipase A2 which leads to suppression of the synthesis of prostaglandins and leukotrienes. Suppresses the release of COX (mainly COX-2), which also helps to reduce production of prostaglandins.

Reduces the number of circulating lymphocytes (T-and B-cells), monocytes, eosinophils and basophils as a result of their displacement from the vascular bed to lymphoid tissue, suppresses the formation of antibodies.

LYCOR CREAM suppresses the release of pituitary ACTH and beta-lipotropin but does not reduce the level of circulating beta-endorphin. Inhibits the secretion of TSH and FSH.

With direct application of the receptacles has a vasoconstrictor effect.

LYCOR CREAM has a pronounced dose-dependent effect on the metabolism of carbohydrates, proteins and fats. Stimulates gluconeogenesis, promotes the capture of amino acids by the liver and kidneys and increases the activity of enzymes of gluconeogenesis. In the liver of LYCOR CREAM increases glycogen deposition by stimulating the activity of glycogen synthase and synthesis of glucose from the products of protein metabolism. Increased blood glucose activates the secretion of insulin.

LYCOR CREAM suppresses the seizure of glucose by fat cells that leads to activation of lipolysis. However, due to increased secretion of insulin is stimulation of lipogenesis which leads to the accumulation of fat.

This medication has catabolic effect in lymphoid and connective tissue, muscle, adipose tissue, skin, bone tissue; to a lesser extent than the mineralocorticoid affects the processes of water and electrolyte metabolism: promotes the excretion of potassium ions and calcium, delay in the body of sodium and water. Osteoporosis and Itsenko-Cushing\'s syndrome are the main factors limiting the long-term therapy of GCS. As a result of catabolic actions may suppress growth in children.

In high doses LYCOR CREAM may increase the excitability of brain tissue and contributes to lowering the threshold of convulsive readiness. It stimulates the excessive production of hydrochloric acid and pepsin in the stomach that promotes the development of peptic ulcers.

For systems use therapeutic activity of LYCOR CREAM caused by anti-inflammatory, anti-allergic, immunosuppressive and antiproliferative action. When external and local application the therapeutic activity of LYCOR CREAM is due to anti-inflammatory, anti-allergic and antiexudative (due to vasoconstrictor effect) action. For anti-inflammatory activity this medicine is 4 times weaker than prednisolone, at mineralocorticoid activity is superior to other GCS.

LYCOR CREAM is the most important human glucocorticoid. It is essential for life and regulates or supports a variety of important cardiovascular, metabolic, immunologic and homeostatic functions. Topical LYCOR CREAM is used for its anti-inflammatory or immunosuppressive properties to treat inflammation due to corticosteroid-responsive dermatoses. Glucocorticoids are a class of steroid hormones characterised by an ability to bind with the cortisol receptor and trigger a variety of important cardiovascular, metabolic, immunologic and homeostatic effects. Glucocorticoids are distinguished from mineralocorticoids and sex steroids by having different receptors, target cells, and effects. Technically, the term corticosteroid refers to both glucocorticoids and mineralocorticoids, but is often used as a synonym for glucocorticoid. Glucocorticoids suppress cell-mediated immunity. They act by inhibiting genes that code for the cytokines IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8 and TNF-alpha, the most important of which is the IL-2. Reduced cytokine production limits T cell proliferation. Glucocorticoids also suppress humoral immunity, causing B cells to express lower amounts of IL-2 and IL-2 receptors. This diminishes both B cell clonal expansion and antibody synthesis. The diminished amounts of IL-2 also leads to fewer T lymphocyte cells being activated.

LYCOR CREAM is a topical steroid. It reduces the actions of chemicals in the body that cause inflammation, redness, and swelling.

LYCOR CREAM topical is used to treat inflammation of the skin caused by a number of conditions such as allergic reactions, eczema, or psoriasis.

LYCOR CREAM is similar to a hormone produced naturally by your body. LYCOR CREAM is used as hormone replacement therapy to replace this natural hormone. LYCOR CREAM is also used to relieve skin inflammation, allergic reactions and to treat some types of rheumatism, asthma, eye, intestinal or blood disorders. LYCOR CREAM may also be used to treat other conditions as decided by your doctor. LYCOR CREAM belongs to a group of medicines called steroids.

Oral Replacement therapy in adrenocortical insufficiency

Adult: 20-30 mg daily in 2 divided doses.

Child: 400-800 mcg/kg/day, in 2-3 divided doses. Intravenous As supplement in adrenal insufficiency during minor surgery under general anaesthesia

Adult: In patients taking >10 mg of prednisolone or its equivalent by mouth daily. 25-50 mg at induction. Resume with usual oral corticosteroid after surgery. Intravenous As supplement in adrenal insufficiency during moderate or major surgery

Adult: In patients taking >10 mg of prednisolone or its equivalent by mouth daily. Usual oral corticosteroid dose on the morning of the surgery followed by 25-50 mg at induction, then similar doses of LYCOR CREAM tid for 24 hr after moderate surgery or 48-72 hr after major surgery. Resume oral therapy once injections are stopped. Intravenous Acute adrenocortical insufficiency

Adult: 100-500 mg 3-4 times/24 hr according to the severity of the condition and patient response. Fluids and electrolytes should be administered as needed to correct any metabolic disorder. Doses may also be given via IM inj but the response may be slower.

Child: <1 yr: 25 mg; 1-5 yr: 50 mg; 6-12 yr: 100 mg. Fluids and electrolytes should be administered as needed to correct any metabolic disorder. Doses may also be given via IM inj but the response may be slower. Injection Soft tissue inflammation

Adult: As Na phosphate or Na succinate esters: 100-200 mg as local inj. Intra-articular Joint inflammations

Adult: As acetate: 5-50 mg depending on size of affected joint. Topical/Cutaneous Corticosteroid-responsive dermatoses

Adult: Apply a 0.1-2.5% cream/ointment/lotion onto affected area.

LYCOR CREAM helps to relieve itch and minor skin irritations. It can also relieve symptoms caused by dermatitis, eczema and psoriasis. LYCOR CREAM belongs to a group of medicines called steroids.

Indications:

Adult: PO Adrenocortical insufficiency 20-30 mg/day in 2 divided doses. IV Supplement in adrenal insufficiency during surgery under general anesth Patients taking >10 mg/day prednisolone or its equivalent by mouth: 25-50 mg at induction. Minor surgery: Resume usual oral dose after surgery; Moderate and major surgery: Administer usual oral corticosteroid dose on the morning of the surgery, then IV induction dose,continue w/ similar IV doses 3 times/day for 24 hr after moderate surgery or 48-72 hr after major surgery; resume usual oral dose after inj are stopped. Acute adrenocortical insufficiency 100-500 mg 3-4 times/24 hr depending on severity and response. Inj Soft-tissue inflammation As Na phosphate or Na succinate esters: 100-200 mg as local inj. Topical Corticosteroid-responsive dermatoses As 0.1-2.5% oint/cream/lotion: Apply as directed. Intra-articular Joint inflammations As acetate: 5-50 mg depending on size of affected joint.

Oral Replacement therapy in adrenocortical insufficiency

Adult: 20-30 mg daily in 2 divided doses.

Child: 400-800 mcg/kg/day, in 2-3 divided doses. Intravenous As supplement in adrenal insufficiency during minor surgery under general anesth

Adult: In patients taking >10 mg of prednisolone or its equivalent by mouth daily. 25-50 mg at induction. Resume with usual oral corticosteroid after surgery. Intravenous As supplement in adrenal insufficiency during moderate or major surgery

Adult: In patients taking >10 mg of prednisolone or its equivalent by mouth daily. Usual oral corticosteroid dose on the morning of the surgery followed by 25-50 mg at induction, then similar doses of LYCOR CREAM tid for 24 hr after moderate surgery or 48-72 hr after major surgery. Resume oral therapy once injections are stopped. Intravenous Emergency treatment for acute adrenocortical insufficiency caused by addisonian or post-adrenaloctomy crisis, abrupt withdrawal of corticosteroid therapy, adrenal insufficiency, anaphylaxis, acute severe asthma, shock

Adult: 100-500 mg 3-4 times/24 hr according to the severity of the condition and patient response.

Child: 6-12 yr: 100 mg; 1-5 yr: 50 mg; <1 yr: 25 mg. Topical/Cutaneous Skin disorders

Adult: Apply a 0.1-2.5% cream/ointment/lotion onto affected area. Intra-articular Joint inflammations

Adult: As acetate: 5-50 mg depending on size of affected joint. Injection Soft tissue inflammation

Adult: As Na phosphate or Na succinate esters: 100-200 mg as local inj.

LYCOR CREAM Pharmafair is a glucocorticosteroid. LYCOR CREAM Pharmafair inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Pharmetics is a glucocorticosteroid. LYCOR CREAM Pharmetics inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM USL Pharmaceuticals is a glucocorticosteroid. LYCOR CREAM USL Pharmaceuticals inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Boots is a glucocorticosteroid. LYCOR CREAM Boots inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Anabolic Laboratories is a glucocorticosteroid. LYCOR CREAM Anabolic Laboratories inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Panray is a glucocorticosteroid. LYCOR CREAM Panray inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Whiteworth Town is a glucocorticosteroid. LYCOR CREAM Whiteworth Town inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Everylife is a glucocorticosteroid. LYCOR CREAM Everylife inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Quad Pharmaceuticals is a glucocorticosteroid. LYCOR CREAM Quad Pharmaceuticals inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Farmak is a glucocorticosteroid. LYCOR CREAM Farmak inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Ferrante is a glucocorticosteroid. LYCOR CREAM Ferrante inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Lannett is a glucocorticosteroid. LYCOR CREAM Lannett inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Alpharma is a glucocorticosteroid. LYCOR CREAM Alpharma inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Novopharm is a glucocorticosteroid. LYCOR CREAM Novopharm inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Tatchempharmpreparaty is a glucocorticosteroid. LYCOR CREAM Tatchempharmpreparaty inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Ambix Laboratories is a glucocorticosteroid. LYCOR CREAM Ambix Laboratories inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM Stiefel Laboratories is a glucocorticosteroid. LYCOR CREAM Stiefel Laboratories inhibits the function of leukocytes and tissue macrophages. The migration of leukocytes in the area of inflammation. Impair the capacity of macrophages to phagocytosis and the formation of interleukin-1. Contributes to the stabilization of lysosomal membranes, thereby reducing the concentration of proteolytic enzymes in the field of inflammation. Decreases capillary permeability due to histamine release. Inhibits activity of fibroblasts and collagen formation.

LYCOR CREAM has a pronounced dose-dependent effect on the metabolism of carbohydrates, proteins and fats. Stimulates gluconeogenesis, promotes the capture of amino acids by the liver and kidneys and increases the activity of enzymes of gluconeogenesis. In the liver of LYCOR CREAM increases glycogen deposition by stimulating the activity of glycogen

Indications: Replacement therapy: Adrenal insufficiency.

Adrenogenital syndrome.

Nonendocrine diseases: Rheumatoid arthirits.

Osteoarthritis, Acute gouty arthirits.

Collagen diseases e.

g.

systemic lupus erythematosus, polyarteritis nodosa, dermatomyositis, nephritic syndrome, glomerulonephritis and related diseases.

Severe allergic reactions e.

g.

anaphylaxis, angioneurotic edema, urticaria and serum sickness and related diseases.

Autoimmune diseases e.

g.

haemolytic anaemia, idiopathic thrombocytopenic purpura, active chronic hepatitis and related diseases.

Other lung diseases e.

g.

pulmonary edema, accelerate lung maturation and surfactant production in the foetus and prevent respiratory distress syndrome at birth.

Infective diseases e.

g.

severe forms of tuberculosis, severe lepra reaction, certain forms of bacterial meningitis and Pneumocystis carinii pneumonia with hypoxia in AIDS patients along with proper antibiotic c

Active ingredients: Hydrocortisone
Unit description, dosagePrice, USD
LYCOR CREAM Cream/ Gel/ Ointment / 1(%) (15gm units)$ 0.93

List of lycor cream brand and generic drugs

LYCORTIN - S
LYCORTIN - S Injection / 100mg (1 units)$ 0.81
Lycortin-S (India)
Lycortin-S 100mg VIAL / 3ml$ 0.81
Lycortin-S 200mg VIAL / 5ml$ 1.46
100 mg x 3ml$ 0.81
200 mg x 5ml$ 1.46
Lyo-Cortin (Greece)
M Hydrocortisone (New Zealand)
Maintasone
Martindale Hydrocortisone (Hongkong)
Martindale Hydrocortisone 1 % x 3 g
Massengill Medicated Soft Cloth Towelette
Massengill Towelette (United States)
Medrocil (Argentina)
Meusicort
Micort-HC (United States)
Cream; Topical; Hydrocortisone Acetate 2%
Cream; Topical; Hydrocortisone Acetate 2.5%
28.4 gram in 1 tube
Microsona (Argentina, Mexico)
Cream; Topical; Hydrocortisone 0.5%
Cream; Topical; Hydrocortisone 1%
Cream; Topical; Hydrocortisone 2%
Mildison (United Kingdom)
Cream; Topical; Hydrocortisone 1%
Mildison Lipid (Denmark, Iceland, Norway, Sweden)
Mildison Lipocream (United Kingdom)
Cream; Topical; Hydrocortisone 1%
Milliderm
Mitocortyl (France)
Mitocortyl Demangeaisons
Cream; Topical; Hydrocortisone 0.5%
Muni (Germany)
Muni 20 g
Muni HC (Germany)
Munitren H
Ointment, Fatty; Topical; Hydrocortisone
Ointment; Topical; Hydrocortisone
Mycort
Mycort 100mg VIAL / 1$ 1.11
Mylocort (South Africa)
Neo-HC
Cream; Topical; Hydrocortisone Acetate 2%
Neopolygramin H
Neopolygramin H Skin 3 gm Ointment$ 0.09
Neosporin-H Ear
Neuroderm Akut (Germany)
Neutrogena T / Scalp
Niscort (India)
Niscort - VIAL / 1$ 0.78
1's$ 0.78
Nitten HC Solone (Japan)
No More Itchies
Nogenic HC
Cream; Topical; Hydrocortisone 1%

Show all LYCOR CREAM generic names
 
Privacy Policy
© 2003 - 2014 igenericdrugs.com All Rights Reserved
 
Disclamer